![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PQLC3 |
Gene summary for PQLC3 |
![]() |
Gene information | Species | Human | Gene symbol | PQLC3 | Gene ID | 130814 |
Gene name | solute carrier family 66 member 3 | |
Gene Alias | C2orf22 | |
Cytomap | 2p25.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q8N755 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
130814 | PQLC3 | P2T-E | Human | Esophagus | ESCC | 7.70e-21 | 3.60e-01 | 0.1177 |
130814 | PQLC3 | P4T-E | Human | Esophagus | ESCC | 3.46e-19 | 4.79e-01 | 0.1323 |
130814 | PQLC3 | P5T-E | Human | Esophagus | ESCC | 4.71e-15 | 2.85e-01 | 0.1327 |
130814 | PQLC3 | P8T-E | Human | Esophagus | ESCC | 1.35e-19 | 4.17e-01 | 0.0889 |
130814 | PQLC3 | P9T-E | Human | Esophagus | ESCC | 2.66e-16 | 3.36e-01 | 0.1131 |
130814 | PQLC3 | P10T-E | Human | Esophagus | ESCC | 8.17e-46 | 8.38e-01 | 0.116 |
130814 | PQLC3 | P11T-E | Human | Esophagus | ESCC | 1.58e-16 | 7.11e-01 | 0.1426 |
130814 | PQLC3 | P12T-E | Human | Esophagus | ESCC | 3.85e-53 | 1.36e+00 | 0.1122 |
130814 | PQLC3 | P15T-E | Human | Esophagus | ESCC | 7.31e-21 | 5.17e-01 | 0.1149 |
130814 | PQLC3 | P16T-E | Human | Esophagus | ESCC | 6.68e-14 | 2.17e-01 | 0.1153 |
130814 | PQLC3 | P17T-E | Human | Esophagus | ESCC | 2.95e-04 | 2.28e-01 | 0.1278 |
130814 | PQLC3 | P19T-E | Human | Esophagus | ESCC | 2.13e-08 | 6.97e-01 | 0.1662 |
130814 | PQLC3 | P20T-E | Human | Esophagus | ESCC | 8.43e-24 | 5.72e-01 | 0.1124 |
130814 | PQLC3 | P21T-E | Human | Esophagus | ESCC | 5.89e-64 | 1.25e+00 | 0.1617 |
130814 | PQLC3 | P22T-E | Human | Esophagus | ESCC | 5.45e-36 | 6.52e-01 | 0.1236 |
130814 | PQLC3 | P23T-E | Human | Esophagus | ESCC | 4.86e-21 | 5.04e-01 | 0.108 |
130814 | PQLC3 | P24T-E | Human | Esophagus | ESCC | 1.04e-18 | 4.29e-01 | 0.1287 |
130814 | PQLC3 | P26T-E | Human | Esophagus | ESCC | 5.69e-35 | 6.51e-01 | 0.1276 |
130814 | PQLC3 | P27T-E | Human | Esophagus | ESCC | 2.31e-16 | 3.25e-01 | 0.1055 |
130814 | PQLC3 | P28T-E | Human | Esophagus | ESCC | 2.59e-23 | 4.46e-01 | 0.1149 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Thyroid | PTC | ![]() |
Thyroid | goiters | ![]() |
Thyroid | ATC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PQLC3 | SNV | Missense_Mutation | rs772145693 | c.316A>G | p.Ile106Val | p.I106V | Q8N755 | protein_coding | tolerated(0.91) | benign(0) | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | rs761512561 | c.337N>G | p.Ile113Val | p.I113V | Q8N755 | protein_coding | tolerated(0.22) | benign(0.007) | TCGA-AA-3952-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
PQLC3 | SNV | Missense_Mutation | novel | c.520C>A | p.Leu174Ile | p.L174I | Q8N755 | protein_coding | deleterious(0.02) | benign(0.189) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
PQLC3 | SNV | Missense_Mutation | novel | c.350N>G | p.Ala117Gly | p.A117G | Q8N755 | protein_coding | tolerated(0.07) | benign(0.354) | TCGA-AG-3896-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | novel | c.343N>T | p.Asp115Tyr | p.D115Y | Q8N755 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | c.369C>A | p.Phe123Leu | p.F123L | Q8N755 | protein_coding | tolerated(1) | benign(0) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD | |
PQLC3 | SNV | Missense_Mutation | rs140598852 | c.160N>T | p.Arg54Trp | p.R54W | Q8N755 | protein_coding | deleterious(0.02) | probably_damaging(0.988) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | novel | c.436A>G | p.Ser146Gly | p.S146G | Q8N755 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-B5-A0JU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | novel | c.308C>A | p.Ser103Tyr | p.S103Y | Q8N755 | protein_coding | deleterious(0.01) | possibly_damaging(0.541) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PQLC3 | SNV | Missense_Mutation | rs138558048 | c.577C>T | p.Arg193Cys | p.R193C | Q8N755 | protein_coding | tolerated(0.1) | possibly_damaging(0.549) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |